Conexeu Sciences Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Conexeu Sciences Inc.'s yearly results, compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Net Worth Ratio: Of every $100 of net worth, $98 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than 87% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
—Data incomplete
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
98%Of every $100 the company owns, $98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 83% of Healthcare companies in United States.
Tangible Net Worth Ratio
98%Of every $100 of net worth, $98 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 87% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
Conexeu Sciences Inc. made a loss over the last year. Conexeu Sciences Inc. owes $0.18 for every $1 it owns. Conexeu Sciences Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Oct 2025.
P/E ratio
LossConexeu Sciences Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
15.91The share price is 15.91 times Conexeu Sciences Inc.'s book value per share, higher than 91% of Healthcare companies in United States.
Market cap
$93 MThe total market value of all of Conexeu Sciences Inc.'s shares at today's price (share price × number of shares), smaller than 67% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$6 MWhat Conexeu Sciences Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Jul 2026).
Book value per share
$0.21Net worth divided by the number of shares. The share price of $3.30 is 15.9 times this, which is the P/B above.
Return on equity (ROE)
-332.9%Conexeu Sciences Inc. lost 332.9% of its shareholders' money over the last year, lower than 90% of Healthcare companies in United States.
Owes vs Owns
0.18×Conexeu Sciences Inc. owes $0.18 for every $1 it owns (low), lower than 75% of Healthcare companies in United States.
Dividend yield
NoneConexeu Sciences Inc. does not currently pay a dividend.
Profit growth
LossConexeu Sciences Inc. made a loss in each of the last two years.
Interest cover
Not coveredConexeu Sciences Inc.'s operating profit did not cover its interest costs in the year to Oct 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Conexeu Sciences Inc.: $93 M ÷ $6 M (31 Jul 2026) = 15.9.
What is Conexeu Sciences Inc.'s return on equity?
Conexeu Sciences Inc. lost 332.9% of its shareholders' money over the last year, lower than 90% of Healthcare companies in United States.
How much does Conexeu Sciences Inc. owe compared with what it owns?
Conexeu Sciences Inc. owes $0.18 for every $1 it owns (low), lower than 75% of Healthcare companies in United States.
Does Conexeu Sciences Inc. pay a dividend?
No. Conexeu Sciences Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.